A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery

NCT ID: NCT00522860

Last Updated: 2012-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

1300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-03-31

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Trachoma is the leading infectious cause of blindness worldwide. Recurrent infection by Chlamydia trachomatis causes in-turning of the eyelids / lashes (trichiasis), leading to corneal damage and blindness. The WHO recommends corrective eyelid surgery for trichiasis. Unfortunately, trichiasis frequently returns following surgery. The purpose of this study is to compare the outcome of surgery (at one and two years) for trichiasis using two currently used alternative suture types: non-absorbable (silk) and absorbable (vicryl). We, the researchers, hypothesise that the supportive presence of the absorbable suture for a longer period produces more stable wound healing, leading to a better outcome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary outcome measure:

Recurrent trichiasis, defined as one or more eyelashes touching the globe or evidence of epilation (lash stubs) on examination, or a history of repeat trichiasis surgery since the baseline surgery, at one year.

Justification of primary outcome:

The aim of surgery is a permanent solution for trichiasis. If a patient has eyelashes touching the eyeball or there is clinical evidence that they are epilating to prevent this or they have required repeat trichiasis surgery, surgery can be deemed a failure.

Analysis of primary outcome measure

Intention to treat analysis of risk factors for recurrence.

Primary analysis of primary outcome:

It is expected that the important baseline characteristics (those that are known to affect the risk of recurrence) will be balanced between the two arms by stratified (for operating surgeon) randomisation. If this is found to be the case, the outcome of the surgery in the two arms will be compared in an unadjusted logistic regression model for recurrent trichiasis at one year. If the arms are found to be substantially imbalanced with respect to, pre-operative severity, gender or age, an appropriately adjusted logistic regression model will be used.

Individuals will be considered to be recurrent trichiasis cases if they have developed recurrent trichiasis at anytime during the one year follow-up period.

Secondary analysis of primary outcome:

1. Effect modification We will assess effect modification of the intervention on recurrence at one year with the following factors by including an interaction term with treatment arm in the logistic regression model.

1. Operating surgeon
2. Pre-operative severity
3. Sex
4. Age group
5. Conjunctival (papillary) inflammation
6. Surgical complications
2. Analysis of risk factors for recurrence:

A multivariate logistic regression model will be used to identify potential explanatory factors for recurrent trichiasis at one year, in addition to the randomised suture type allocation. Other factors which will be examined in a model of recurrent trichiasis will include
1. pre-operative disease severity

* trichiasis
* entropion
* corneal opacity
2. surgeon
3. infection status at baseline and follow up timepoints
4. inflammation status at baseline and follow up timepoints
5. whether epilation is being practised
6. sex
7. age
8. geographic location of patient's home
9. literacy
10. body mass index
11. eye dryness

* symptoms
* signs
3. Impact of intervention on time-to-first-recurrence. Kaplan-Meier analysis will be used to plot the survival curves for both treatment arms up to the final visit at 2 years. Cox regression will be used to assess the impact of the intervention on time to first recurrence. The hazard ratio will be estimated with Cox regression, adjusting for substantial baseline imbalances if appropriate.
4. Recurrence at two years Intention-to-treat analysis will be used to assess the impact of the intervention on failure at 2 years. Failure will be defined as one or more eyelashes touching the globe or evidence of epilation (lash stubs) on examination, or a history of repeat trichiasis surgery since the baseline surgery, at either one year and/or two year follow-up visits.

Secondary outcome measures

1. Lashes touching the eyeball The effect of the intervention on the number of lashes touching at one, and two years, respectively, will be analysed using zero inflated Poisson regression (i.e. treating number of lashes as a continuous variable)
2. Entropion grade The effect of the intervention on the degree of entropion will be analysed by ordered logistic regression
3. Conjunctivilisation of the lid margin grade The effect of the intervention on the degree of conjunctivilisation will be analysed by ordered logistic regression
4. Clinical evidence of epilation The effect of the intervention on clinical evidence of epilation will be assessed at one and two years respectively with logistic regression. In addition, Cox regression will be used to analyse time-to-first evidence of epilation.
5. Repeat surgery The effect of the intervention on the proportion with repeat surgery will be assessed at one and two years respectively with logistic regression. In addition, Cox regression will be used to analyse time-to-first evidence of first repeat surgery.
6. Recurrence (lashes touching the eyeball, clinical evidence of epilation, repeat surgery) + history of epilation A secondary definition of recurrence will incorporate self-reported history of epilation. The primary analyses will be repeated with this definition of recurrence.
7. Corneal opacification (CO) (categorical variable)

1. Descriptive measures of the baseline severity of CO
2. Description of the change in CO between baseline and one and two year follow up time-points.
3. Ordered logistic regression analysis for factors associated with change in CO at one year and two years, respectively, including to identify factors associated with it, such as suture type and inflammation.
8. Visual acuity (VA) (categorical variable) The effect of the intervention on the visual acuity (logMAR score) at 12 and 24 months will be analysed by linear regression.
9. Surgical complications

Surgical complications other than recurrence, such as granuloma, incomplete lid closure, inflammation (secondary to either of the two sutures materials) and infection can occur. Descriptive statistics, with significance testing will be used to compare the rates of occurrence of all complications and individual complications at any time during the study period between the two arms of the study.
10. Patient satisfaction

Patients are asked the following questions on the follow up questionnaires that indicate their satisfaction with the procedure:

1. Do you think your vision is worse, the same or better than before your surgery?
2. Do you have eye pain?
3. If you have eye pain is it worse, the same or better than before the operation?
4. Do your eyes water?
5. Did you find the surgery painful?
6. If the eyelashes have returned or will return would you seek further surgery?

The proportion answering 'yes' to each of these questions will be compared between the two arms of the trial.

Additionally the answers to questions (b) and (d) will be compared between baseline (pre-operative) and the answer given at each time point within each arm.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trachomatous Trichiasis Trachoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vicryl Suture

Vicryl sutures, 5/0, 3/8 curved cutting needle

Group Type EXPERIMENTAL

Trichiasis surgery with absorbable sutures

Intervention Type PROCEDURE

Posterior lamellar tarsal rotation. Vicryl sutures, 5/0, 3/8 curved needle, cutting. Three everting sutures.

Silk Suture

Silk suture, 4/0, 3/8 curved cutting needle

Group Type ACTIVE_COMPARATOR

Trichiasis surgery with non-absorbable sutures

Intervention Type PROCEDURE

Posterior lamellar tarsal rotation. Silk sutures. 4/0. 3/8 curved cutting needle. Three sets of everting sutures.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trichiasis surgery with absorbable sutures

Posterior lamellar tarsal rotation. Vicryl sutures, 5/0, 3/8 curved needle, cutting. Three everting sutures.

Intervention Type PROCEDURE

Trichiasis surgery with non-absorbable sutures

Posterior lamellar tarsal rotation. Silk sutures. 4/0. 3/8 curved cutting needle. Three sets of everting sutures.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major trichiasis: more than 5 lashes touching the eye

Exclusion Criteria

* Previous eyelid surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

London School of Hygiene and Tropical Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matthew J Burton, PhD FRCOphth

Role: PRINCIPAL_INVESTIGATOR

London School of Hygiene and Tropical Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bahir Dar Regional Health Bureau

Bahir Dar, Amhara, Ethiopia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ethiopia

References

Explore related publications, articles, or registry entries linked to this study.

Rajak SN, Habtamu E, Weiss HA, Kello AB, Gebre T, Genet A, Bailey RL, Mabey DC, Khaw PT, Gilbert CE, Emerson PM, Burton MJ. Absorbable versus silk sutures for surgical treatment of trachomatous trichiasis in Ethiopia: a randomised controlled trial. PLoS Med. 2011 Dec;8(12):e1001137. doi: 10.1371/journal.pmed.1001137. Epub 2011 Dec 13.

Reference Type RESULT
PMID: 22180732 (View on PubMed)

Gower EW, Munoz B, Rajak S, Habtamu E, West SK, Merbs SL, Harding JC, Alemayehu W, Callahan EK, Emerson PM, Gebre T, Burton MJ. Pre-operative trichiatic eyelash pattern predicts post-operative trachomatous trichiasis. PLoS Negl Trop Dis. 2019 Oct 7;13(10):e0007637. doi: 10.1371/journal.pntd.0007637. eCollection 2019 Oct.

Reference Type DERIVED
PMID: 31589610 (View on PubMed)

Rajak SN, Habtamu E, Weiss HA, Bedri A, Zerihun M, Gebre T, Gilbert CE, Emerson PM, Burton MJ. Why do people not attend for treatment for trachomatous trichiasis in Ethiopia? A study of barriers to surgery. PLoS Negl Trop Dis. 2012;6(8):e1766. doi: 10.1371/journal.pntd.0001766. Epub 2012 Aug 28.

Reference Type DERIVED
PMID: 22953007 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Suture Closure Trial
NCT05261425 ACTIVE_NOT_RECRUITING NA